Pharmstandard – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Pharmstandard develops, manufactures and distributes pharmaceutical products. The company offers prescription pharmaceuticals and over-the drug (OTC) pharmaceuticals. It also provides contract manufacturing services. Pharmstandard’s product portfolio includes drugs for treatments of cardio-vascular diseases, cancer, gastroenterology diseases, neurology diseases, diabetes, contagious diseases, growth hormone deficiency, metabolic disorders and other diseases. The company serves customers in The Commonwealth of Independent States and Former Soviet Union countries. Pharmstandard is headquartered in Dolgoprudny, Moscow, Russia.

Pharmstandard Key Recent Developments

Jun 22,2020: Pharmstandard-Leksredstva will upgrade its production facilities
Jun 11,2020: Pharmstandard transferred critical SAP business systems to Croc Data Centre
Jun 10,2020: Pharmstandard digital ecosystem project gets Platinum Ounce
Mar 25,2020: Pharmstandard-UfaVITA shall manufacture solutions in polymer package

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.